AMAG Pharmaceuticals PEG
What is the PEG of AMAG Pharmaceuticals?
The PEG of AMAG Pharmaceuticals, Inc. is N/A
What is the definition of PEG?
Price/earnings to growth (PEG) ratio is a stock’s P/E ratio divided by a predicted growth rate of its earnings for a time period of 5 years.
= forward PE / 5-year EPS growth rate
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG of companies in the Health Care sector on NASDAQ compared to AMAG Pharmaceuticals
What does AMAG Pharmaceuticals do?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Companies with peg similar to AMAG Pharmaceuticals
- Diamondrock Hospitality Co has PEG of N/A
- KVH Industries has PEG of N/A
- GESCO AG has PEG of N/A
- Cronos has PEG of N/A
- Cairn Plc has PEG of N/A
- Arcos Dorados Inc has PEG of N/A
- AMAG Pharmaceuticals has PEG of N/A
- CVR Inc has PEG of N/A
- Polymet Mining Corp has PEG of N/A
- Diana Shipping Inc has PEG of N/A
- Verastem Inc has PEG of N/A
- Stanley Furniture has PEG of N/A
- Hutchison Telecommunications Hong Kong has PEG of N/A